Abstract
Antisense agents are powerful tools to inhibit gene expression in a sequencespecific manner. They are used for functional genomics, as diagnostic tools and for therapeutic purposes. Three classes of antisense agents can be distinguished by their mode of action: single-stranded antisense oligodeoxynucleotides; catalytic active RNA/DNA such as ribozymes, DNA- or locked nucleic acid (LNA)zymes; and small interfering RNA molecules known as siRNA. The selection of target sites in highly structured RNA molecules is crucial for their successful application. This is a difficult task, since RNA is assembled into nucleoprotein complexes and forms stable secondary structures in vivo, rendering most of the molecule inaccessible to intermolecular base pairing with complementary nucleic acids. In this review, we discuss several selection strategies to identify potential target sites in RNA molecules. In particular, we focus on combinatorial library approaches that allow high throughput screening of sequences for the design of antisense agents.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Allawi HT, Dong F, Ip HS, Neri BP, Lyamichev VI (2001) Mapping of RNA accessible sites by extension of random oligonucleotide libraries with reverse transcriptase. RNA 7:314–327
Barroso-DelJesus A, Berzal-Herranz A (2001) Selection of targets and the most efficient hairpin ribozymes for inactivation of mRNAs using a self-cleaving RNA library. EMBO Rep 2:1112–1118
Berns K, Hijmans EM, Mullenders J, Brummelkamp TR, Velds A, Heimerikx M, Kerkhoven RM, Madiredjo M, Nijkamp W, Weigelt B, Agami R, Ge W, Cavet G, Linsley PS, Beijersbergen RL, Bernards R (2004) A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 428:431–437
Birikh KR, Berlin YA, Soreq H, Eckstein F (1997a) Probing accessible sites for ribozymes on human acetylcholinesterase RNA. RNA 3:429–437
Birikh KR, Heaton PA, Eckstein F (1997b) The structure, function and application of the hammerhead ribozyme. Eur J Biochem 245:1–16
Brunel C, Ehresmann B, Ehresmann C, McKeown M (2001) Selection of genomic target RNAs by iterative screening. Bioorg Med Chem 9:2533–2541
Cairns MJ, Hopkins TM, Witherington C, Wang L, Sun LQ (1999) Target site selection for an RNA-cleaving catalytic DNA. Nat Biotechnol 17:480–486
Chalk AM, Wahlestedt C, Sonnhammer EL (2004) Improved and automated prediction of effective siRNA. Biochem Biophys Res Commun 319:264–274
Chen TZ, Lin SB, Wu JC, Choo KB, Au LC (1996) A method for screening antisense oligodeoxyribonucleotides effective for mRNA translation-arrest. J Biochem (Tokyo) 119:252–255
Crooke ST (2004) Progress in antisense technology. Annu Rev Med 55:61–95
Dausse E, Cazenave C, Rayner B, Toulme JJ (2005) In vitro selection procedures for identifying DNA and RNA aptamers targeted to nucleic acids and proteins. Methods Mol Biol 288:391–410
Donis-Keller H (1979) Site specific enzymatic cleavage of RNA. Nucleic Acids Res 7:179–192
Dunn SJ, Park SW, Sharma V, Raghu G, Simone JM, Tavassoli R, Young LM, Ortega MA, Pan CH, Alegre GJ, Roninson IB, Lipkina G, Dayn A, Holzmayer TA (1999) Isolation of efficient antivirals: genetic suppressor elements against HIV-1. Gene Ther 6:130–137
Ehresmann C, Baudin F, Mougel M, Romby P, Ebel JP, Ehresmann B (1987) Probing the structure of RNAs in solution. Nucleic Acids Res 15:9109–9128
Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494–498
Gee JE, Robbins I, van der Laan AC, van Boom JH, Colombier C, Leng M, Raible AM, Nelson JS, Lebleu B (1998) Assessment of high-affinity hybridization, RNase H cleavage, and covalent linkage in translation arrest by antisense oligonucleotides. Antisense Nucleic Acid Drug Dev 8:103–111
Good L (2003a) Diverse antisensemechanisms and applications. Cell Mol Life Sci 60:823–824
Good L (2003b) Translation repression by antisense sequences. Cell Mol Life Sci 60:854–861
Gudkov AV, Zelnick CR, Kazarov AR, Thimmapaya R, Suttle DP, Beck WT, Roninson IB (1993) Isolation of genetic suppressor elements, inducing resistance to topoisomerase II-interactive cytotoxic drugs, from human topoisomerase II cDNA. Proc Natl Acad Sci U S A 90:3231–3235
Gyllensten UB, Erlich HA (1988) Generation of single-stranded DNA by the polymerase chain reaction and its application to direct sequencing of the HLA-DQA locus. Proc Natl Acad Sci U S A 85:7652–7656
Ho SP, Britton DH, Stone BA, Behrens DL, Leffet LM, Hobbs FW, Miller JA, Trainor GL (1996) Potent antisense oligonucleotides to the human multidrug resistance-1 mRNA are rationally selected by mapping RNA-accessible sites with oligonucleotide libraries. Nucleic Acids Res 24:1901–1907
Holzmayer TA, Pestov DG, Roninson IB (1992) Isolation of dominant negativemutants and inhibitory antisense RNA sequences by expression selection of random DNA fragments. Nucleic Acids Res 20:711–717
Inoue H, Hayase Y, Iwai S, Ohtsuka E (1988) Sequence-specific cleavage of RNA using chimeric DNA splints and RNase H. Nucleic Acids Symp Ser 135–138
Jackson AL, Linsley PS (2004) Noise amidst the silence: off-target effects of siRNAs? Trends Genet 20:521–524
Jackson AL, Bartz SR, Schelter J, Kobayashi SV, Burchard J, Mao M, Li B, Cavet G, Linsley PS (2003) Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol 21:635–637
Jakobsen MR, Damgaard CK, Andersen ES, Podhajska A, Kjems J (2004) Agenomic selection strategy to identify accessible and dimerization blocking targets in the 5′-UTR of HIV-1 RNA. Nucleic Acids Res 32:e67
Kawasaki H, Kuwabara T, Miyagishi M, Taira K (2003a) Identification of functional genes by libraries of ribozymes and siRNAs. Nucleic Acids Res Suppl 331–332
Kawasaki H, Suyama E, Iyo M, Taira K (2003b) siRNAs generated by recombinant human Dicer induce specific and significant but target site-independent gene silencing in human cells. Nucleic Acids Res 31:981–987
Kilani AF, Trang P, Jo S, Hsu A, Kim J, Nepomuceno E, Liou K, Liu F (2000) RNase P ribozymes selected in vitro to cleave a viral mRNA effectively inhibit its expression in cell culture. J Biol Chem 275:10611–10622
Kretschmer-Kazemi Far R, Sczakiel G (2003) The activity of siRNA in mammalian cells is related to structural target accessibility: a comparison with antisense oligonucleotides. Nucleic Acids Res 31:4417–4424
Kurreck J (2003) Antisense technologies. Improvement through novel chemical modifications. Eur J Biochem 270:1628–1644
Lieber A, Strauss M (1995) Selection of efficient cleavage sites in target RNAs by using a ribozyme expression library. Mol Cell Biol 15:540–551
Luetzelberger M, Jakobsen MR, Kjems J (2005) SELEX strategies to identify antisense and protein target sites in RNA or heterogeneous nuclear ribonucleoprotein complexes. In: Hartmann RK, Bindereif A, Schoen A, Westhof E (eds) Handbook of RNA biochemistry, vol 2. Wiley-VCH Verlag GmbH and Co., Weinheim, pp 878–894
Matveeva O, Felden B, Audlin S, Gesteland RF, Atkins JF (1997) A rapid in vitro method for obtaining RNA accessibility patterns for complementary DNA probes: correlation with an intracellular pattern and known RNA structures. Nucleic Acids Res 25:5010–5016
Matveeva O, Felden B, Tsodikov A, Johnston J, Monia BP, Atkins JF, Gesteland RF, Freier SM (1998) Prediction of antisense oligonucleotide efficacy by in vitro methods. Nat Biotechnol 16:1374–1375
Matzke MA, Birchler JA (2005) RNAi-mediated pathways in the nucleus. Nat Rev Genet 6:24–35
McManus MT, Sharp PA (2002) Gene silencing in mammals by small interfering RNAs. Nat Rev Genet 3:737–747
Milner N, Mir KU, Southern EM (1997) Selecting effective antisense reagents on combinatorial oligonucleotide arrays. Nat Biotechnol 15:537–541
Minshull J, Hunt T (1986) The use of single-stranded DNA and RNase H to promote quantitative ‘hybrid arrest of translation’ of mRNA/DNA hybrids in reticulocyte lysate cell-free translations. Nucleic Acids Res 14:6433–6451
Monia BP, Johnston JF, Geiger T, Muller M, Fabbro D (1996) Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase. Nat Med 2:668–675
Myers JW, Jones JT, Meyer T, Ferrell JE Jr (2003) Recombinant Dicer efficiently converts large dsRNAs into siRNAs suitable for gene silencing. Nat Biotechnol 21:324–328
Naito Y, Yamada T, Ui-Tei K, Morishita S, Saigo K (2004) siDirect: highly effective, targetspecific siRNA design software for mammalian RNA interference. Nucleic Acids Res 32:W124–129
Ooms M, Verhoef K, Southern E, Huthoff H, Berkhout B (2004) Probing alternative foldings of the HIV-1 leader RNA by antisense oligonucleotide scanning arrays. Nucleic Acids Res 32:819–827
Paddison PJ, Silva JM, Conklin DS, Schlabach M, Li M, Aruleba S, Balija V, O’shaughnessy A, Gnoj L, Scobie K, Chang K, Westbrook T, Cleary M, Sachidanandam R, McCombie WR, Elledge SJ, Hannon GJ (2004) A resource for large-scale RNA-interference-based screens in mammals. Nature 428:427–431
Pan WH, Devlin HF, Kelley C, Isom HC, Clawson GA (2001) Aselection system for identifying accessible sites in target RNAs. RNA 7:610–621
Petersen M, Wengel J (2003) LNA: a versatile tool for therapeutics and genomics. Trends Biotechnol 21:74–81
Peyman A, Helsberg M, Kretzschmar G, Mag M, Grabley S, Uhlmann E (1995) Inhibition of viral growth by antisense oligonucleotides directed against the IE110 and the UL30 mRNA of herpes simplex virus type-1. Biol Chem Hoppe Seyler 376:195–198
Pickford AS, Cogoni C (2003) RNA-mediated gene silencing. Cell Mol Life Sci 60:871–882
Raj S, Liu F (2004) In vitro selection of external guide sequences for directing human RNase P to cleave a target mRNA. Methods Mol Biol 252:413–424
Raj SM, Liu F (2003) Engineering of RNase P ribozyme for gene-targeting applications. Gene 313:59–69
Ruffner DE, Stormo GD, Uhlenbeck OC (1990) Sequence requirements of the hammerhead RNA self-cleavage reaction. Biochemistry 29:10695–10702
Santoro SW, Joyce GF (1997) A general purpose RNA-cleaving DNA enzyme. Proc Natl Acad Sci U S A 94:4262–4266
Saxena S, Jonsson ZO, Dutta A (2003) Small RNAs with imperfect match to endogenous mRNA repress translation. Implications for off-target activity of small inhibitory RNA in mammalian cells. J Biol Chem 278:44312–44319
Sazani P, Kole R (2003) Modulation of alternative splicing by antisense oligonucleotides. Prog Mol Subcell Biol 31:217–239
Scacheri PC, Rozenblatt-Rosen O, Caplen NJ, Wolfsberg G, Umayam L, Lee JC, Hughes CM, Shanmugam KS, Bhattacharjee A, Meyerson M, Collins FS (2004) Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells. Proc Natl Acad Sci U S A 101:1892–1897
Scherr M, Rossi JJ (1998) Rapid determination and quantitation of the accessibility to native RNAs by antisense oligodeoxynucleotides in murine cell extracts. Nucleic Acids Res 26:5079–5085
Schubert S, Furste JP, Werk D, Grunert HP, Zeichhardt H, Erdmann VA, Kurreck J (2004) Gaining target access for deoxyribozymes. J Mol Biol 339:355–363
Schwarz DS, Hutvagner G, Du T, Xu Z, Aronin N, Zamore PD (2003) Asymmetry in the assembly of the RNAi enzyme complex. Cell 115:199–208
Sen G, Wehrman TS, Myers JW, Blau HM (2004) Restriction enzyme-generated siRNA (REGS) vectors and libraries. Nat Genet 36:183–189
Shibahara S, Mukai S, Nishihara T, Inoue H, Ohtsuka E, Morisawa H (1987) Site-directed cleavage of RNA. Nucleic Acids Res 15:4403–4415
Shirane D, Sugao K, Namiki S, Tanabe M, Iino M, Hirose K (2004) Enzymatic production of RNAi libraries from cDNAs. Nat Genet 36:190–196
Singer BS, Shtatland T, Brown D, Gold L (1997) Libraries for genomic SELEX. Nucleic Acids Res 25:781–786
Sohail M, Southern EM (2000) Selecting optimal antisense reagents. Adv Drug Deliv Rev 44:23–34
Stull RA, Zon G, Szoka FC Jr (1996) An in vitro messenger RNA binding assay as a tool for identifying hybridization-competent antisense oligonucleotides. Antisense Nucleic Acid Drug Dev 6:221–228
Trang P, Kilani A, Kim J, Liu F (2000) A ribozyme derived from the catalytic subunit of RNase P from Escherichia coli is highly effective in inhibiting replication of herpes simplex virus 1. J Mol Biol 301:817–826
Tucholski J, Skowron PM, Podhajska AJ (1995) MmeI, a class-IIS restriction endonuclease: purification and characterization. Gene 157:87–92
Tuerk C, Gold L (1990) Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249:505–510
Ui-Tei K, Naito Y, Takahashi F, Haraguchi T, Ohki-Hamazaki H, Juni A, Ueda R, Saigo K (2004) Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference. Nucleic Acids Res 32:936–948
Vacek M, Sazani P, Kole R (2003) Antisense-mediated redirection of mRNA splicing. Cell Mol Life Sci 60:825–833
Vickers TA, Koo S, Bennett CF, Crooke ST, Dean NM, Baker BF (2003) Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysis. J Biol Chem 278:7108–7118
Vlassov AV, Koval OA, Johnston BH, Kazakov SA (2004) ROLL: a method of preparation of gene-specific oligonucleotide libraries. Oligonucleotides 14:210–220
Wang JY, Drlica K (2004) Computational identification of antisense oligonucleotides that rapidly hybridize to RNA. Oligonucleotides 14:167–175
Wen JD, Gray DM (2004) Selection of genomic sequences that bind tightly to Ff gene 5 protein: primer-free genomic SELEX. Nucleic Acids Res 32:e182
Westerhout EM, Ooms M, Vink M, Das AT, Berkhout B (2005) HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Nucleic Acids Res 33:796–804
Williams KP, Bartel DP (1995) PCR product with strands of unequal length. Nucleic Acids Res 23:4220–4221
Yamada T, Morishita S (2004) Accelerated off-target search algorithm for siRNA. Bioinformatics 21:1316–1324
Zamecnik PC, Stephenson ML (1978) Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. Proc Natl Acad Sci U S A 75:280–284
Zhang HY, Mao J, Zhou D, Xu Y, Thonberg H, Liang Z, Wahlestedt C (2003) mRNA accessible site tagging (MAST): a novel high throughput method for selecting effective antisense oligonucleotides. Nucleic Acids Res 31:e72
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Lützelberger, M., Kjems, J. (2006). Strategies to Identify Potential Therapeutic Target Sites in RNA. In: Erdmann, V., Barciszewski, J., Brosius, J. (eds) RNA Towards Medicine. Handbook of Experimental Pharmacology, vol 173. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27262-3_12
Download citation
DOI: https://doi.org/10.1007/3-540-27262-3_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-27261-8
Online ISBN: 978-3-540-27262-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)